Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Wen-Xiang Cao"'
Autor:
Chen-xu Ni, Yi-bo Fei, Ran Wu, Wen-xiang Cao, Wenhao Liu, Fang Huang, Fu-ming Shen, Dong-jie Li
Publikováno v:
JMIR Formative Research, Vol 8, p e59671 (2024)
Externí odkaz:
https://doaj.org/article/62dd308c555f4367aca78736a96ae394
Autor:
Chen-xu Ni, Yi-bo Fei, Ran Wu, Wen-xiang Cao, Wenhao Liu, Fang Huang, Fu-ming Shen, Dong-jie Li
Publikováno v:
JMIR Formative Research, Vol 8, p e50561 (2024)
BackgroundTumor immunotherapy is an innovative treatment today, but there are limited data on the quality of immunotherapy information on social networks. Dissemination of misinformation through the internet is a major social issue. ObjectiveOur obj
Externí odkaz:
https://doaj.org/article/5109a787366f4fa280e6665778a418d5
Autor:
Fang Huang, Wen-Xiang Cao, Yu-Ying Yan, Tian-Tian Mao, Xian-Wen Wang, Dan Huang, Yu-Shuang Qiu, Wen-Jie Lu, Dong-Jie Li, Yu-Gang Zhuang
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objective: The influence of continuous renal replacement therapy (CRRT) on the steady-state plasma concentration of high-dose tigecycline was investigated in septic shock patients to provide references for drug dosing.Methods: In this prospective obs
Externí odkaz:
https://doaj.org/article/f3acc2b70dd246dcaa86bf073bbcfedd
Publikováno v:
Redox Biology, Vol 12, Iss , Pp 367-376 (2017)
Chelerythrine (CHE), a natural benzo[c]phenanthridine alkaloid, shows anti-cancer effect through a number of mechanisms. Herein, the effect and mechanism of the CHE-induced autophagy, a type II programmed cell death, in non-small cell lung cancer (NS
Externí odkaz:
https://doaj.org/article/cbf5db40e1594a1f805fd684f772449d
Autor:
Qing-Xin Ji, Fei-Yan Zeng, Jian Zhou, Wen-Bin Wu, Xu-Jie Wang, Zhen Zhang, Guo-Yan Zhang, Jie Tong, Di-Yang Sun, Jia-Bao Zhang, Wen-Xiang Cao, Fu-Ming Shen, Jin-Jian Lu, Dong-Jie Li, Pei Wang
Publikováno v:
Cell death and differentiation.
Smooth muscle cell (SMC) phenotypic switch from a quiescent 'contractile' phenotype to a dedifferentiated and proliferative state underlies the development of cardiovascular diseases (CVDs); however, our understanding of the mechanism is still incomp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcc910f611f55a2e6c462223b491d55c
https://pubmed.ncbi.nlm.nih.gov/36477078
https://pubmed.ncbi.nlm.nih.gov/36477078
Publikováno v:
RSC Advances. 7:42597-42605
Autophagy, an evolutionarily conserved cellular self-digestive process, is associated with different diseases and can be inhibited or induced by a series of agents. In this study, we reported that fangchinoline (FCL), an alkaloid from Stephania tetra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80ede90bcc85413f7684d266c05c4e33
https://doi.org/10.1039/c7ra02738a
https://doi.org/10.1039/c7ra02738a
Autor:
Fu-Ming Shen, Wen-Xiang Cao, Yu-Jie Jiang, Xiu-Ting Lan, Dong-Jie Li, Hui Fu, Pei Wang, Si-Jia Sun, Min Ni
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867:165980
Backgrounds and aims Leucine, isoleucine, and valine are diet derived and essential amino acids that are termed branched-chain amino acids (BCAA). BCAA are widely used as dietary supplements to boost muscle growth and enhance exercise performance. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d6543bf5fa542a286256cb684c7b253
https://doi.org/10.1016/j.bbadis.2020.165980
https://doi.org/10.1016/j.bbadis.2020.165980
Autor:
Zhao-Yu Wang, Le-Le Zhang, Zheng-Hai Tang, Xia Guo, Ting Li, Xiuping Chen, Min-Xia Su, Wen-Xiang Cao, Jin-Jian Lu
Publikováno v:
Apoptosis : an international journal on programmed cell death. 23(9-10)
The pseudokinase mixed lineage kinase domain-like protein (MLKL) is a core effector of necroptosis, and its function in necroptosis is widely studied. However, the function of MLKL in apoptosis remains unclear. In the present study, the role of MLKL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc372a8d1ada24ae51feb55e588bbf46
https://pubmed.ncbi.nlm.nih.gov/30084053
https://pubmed.ncbi.nlm.nih.gov/30084053
Autor:
Xiuping Chen, Hong Zhu, Xia Guo, Jia-Hong Lu, Wen-Xiang Cao, Xiaoyang Dai, Jin-Jian Lu, Zheng-Hai Tang
Publikováno v:
Cancer letters. 412
Inhibition of autophagy is a promising strategy for non-small cell lung cancer (NSCLC) treatment, which is in the clinical trials. However, only chloroquine is used in clinic as an autophagic inhibitor and the inhibitory effect of chloroquine on auto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b204cad07309ee5b44cdd99bed57af69
https://pubmed.ncbi.nlm.nih.gov/29024815
https://pubmed.ncbi.nlm.nih.gov/29024815
Publikováno v:
Toxicology and applied pharmacology. 321
Osimertinib (OSI), also known as AZD9291, is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that has been approved for the treatment of non-small cell lung cancer (NSCLC) patients harboring EGFR T790M mutation. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fff0eca88fea1993acf2b3e6f8aaef6
https://pubmed.ncbi.nlm.nih.gov/28237877
https://pubmed.ncbi.nlm.nih.gov/28237877